Introductory
1043Overview of Chapter
(1)This Chapter provides for relief for companies which are small or medium-sized enterprises for expenditure on—
(a)in-house direct research and development, or
(b)contracted out research and development,
where the cost of the research and development is incurred by the company.
(2)The reliefs available are—
(a)an additional deduction under section 1044, or
(b)a deemed trading loss under section 1045.
(3)Sections 1046 to 1053 contain provision relevant to the reliefs available under this Chapter, namely—
(a)provision preventing a company from making a claim or election for relief if it is not a going concern (see section 1046),
(b)information about elections under section 1045 for a deemed trading loss (see section 1047),
(c)information about the treatment of a deemed trading loss (see section 1048),
(d)a restriction on consortium relief where relief is obtained (see section 1049),
(e)provision about when a company meets the R&D threshold for the purposes of obtaining relief (see section 1050), and
(f)provision about when a company’s expenditure is “qualifying Chapter 2 expenditure” for those purposes (see sections 1051 to 1053).
(4)Sections 1054 to 1062 deal with R&D tax credits which can be claimed if a company—
(a)obtains relief under this Chapter, and
(b)makes, or is treated as making, a trading loss.